Kenon
KEN
62.06
+0.54
+0.88%
Kenon
US · KEN
#2440 by market cap
Listed 1970
62.06
+0.54
+0.88%
Live - 5344 symbols - heartbeat 282s ago
· 2026-10-08 05:55
Pre-market
59.81
-3.63%
After-hours
62.06
0.00%
- Market cap
- 3.23B
- P/E (TTM)i
- 27.10
- P/Bi
- 2.07
- EPSi
- 1.27
- Div yieldi
- 6.20%
- 52W posi
- 33%
Reader sentiment
Are you bullish or bearish on KEN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.78, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +16.06% YoY
Margins
- Gross margin
- 16.84%
- Operating margin
- 7.15%
- Net margin
- 7.60%
Key ratios & quality
- Enterprise valuei
- 3.42B
- Altman Z-Scorei
- 1.78
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 364.01M | 373.47M | 386.47M | 487.76M | 573.96M | 691.80M | 751.30M | 871.93M |
| Gross profit | 74.69M | 86.30M | 71.25M | 98.35M | 99.84M | 119.46M | 143.79M | 146.82M |
| Selling & admin expenses | 33.04M | 33.54M | 33.77M | 67.76M | 92.10M | 73.98M | 84.15M | 105.86M |
| Research & development | 999.00K | 1.95M | 2.00M | 1.57M | -- | -- | -- | -- |
| Operating profit | 102.61M | 55.97M | 35.24M | 23.29M | 2.83M | 42.56M | 47.51M | 62.35M |
| Pretax profit | 461.97M | -5.54M | 500.45M | 879.64M | 82.26M | 81.16M | 93.32M | 176.51M |
| Tax | 11.50M | 16.68M | 4.70M | 4.33M | 37.98M | 25.20M | 40.55M | 28.24M |
| Net profit | 444.84M | 2.44M | 504.23M | 875.32M | 349.66M | -210.95M | 634.09M | 148.26M |
| Basic EPS | 8 | 0 | 9 | 17 | 6 | -4 | 11 | 1 |
| Diluted EPS | 8.07 | -0.25 | 9.41 | 17.27 | 5.80 | -4.42 | 11.34 | 1.27 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 183.00M | 196.00M | 265.00M | 227.93M | 317.00M | 379.00M |
| Gross profit | 27.00M | 29.00M | 69.00M | 21.82M | 47.00M | 84.00M |
| Selling & admin expenses | 18.00M | 31.00M | 45.00M | 12.86M | 26.00M | 27.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 9.00M | -2.00M | 34.00M | 21.35M | 4.00M | 36.00M |
| Pretax profit | 36.00M | 7.00M | 82.00M | 51.51M | 43.00M | 67.00M |
| Tax | 9.00M | 1.00M | 15.00M | 3.24M | 9.00M | 13.00M |
| Net profit | 27.00M | 6.00M | 67.00M | 48.26M | 34.00M | 54.00M |
| Basic EPS | 0 | 0 | 0 | 1 | 0 | 1 |
| Diluted EPS | 0.22 | 0.10 | 0.45 | 0.50 | 0.49 | 0.85 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 327.72M | 329.54M | 919.79M | 581.59M | 1.06B | 1.10B | 1.26B | 1.80B |
| Cash & ST investments | 131.12M | 147.15M | 850.43M | 474.77M | 915.61M | 912.64M | 1.16B | 1.59B |
| Inventory | -- | -- | 0 | 1.71M | -- | -- | -- | -- |
| Total assets | 1.46B | 1.51B | 2.48B | 4.04B | 3.77B | 4.11B | 4.21B | 5.38B |
| Total current liabilities | 89.92M | 105.01M | 227.94M | 447.29M | 192.98M | 358.80M | 182.84M | 365.20M |
| Short-term debt | 23.24M | 46.47M | 60.56M | 57.30M | 56.74M | 174.59M | 88.54M | 120.05M |
| Long-term debt | 563.24M | 576.65M | 871.83M | 1.17B | 1.12B | 1.36B | 1.18B | 1.65B |
| Total liabilities | 739,400,000.00 | 796,586,000.00 | 1,206,325,000.00 | 1,758,128,000.00 | 1,476,142,000.00 | 2,038,216,000.00 | 1,553,700,000.00 | 2,195,432,000.00 |
| Total equity | 715.72M | 711.79M | 1.28B | 2.28B | 2.30B | 2.07B | 2.66B | 3.18B |
| Retained earnings | 28.92M | -10.95M | 459.82M | 1.14B | 1.50B | 1.09B | 1.49B | 1.45B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.22B | 1.18B | 1.43B | 1.80B | 2.03B | 2.02B |
| Cash & ST investments | 1.12B | 1.03B | 1.26B | 1.59B | 1.87B | 1.77B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 4.20B | 4.34B | 4.69B | 5.38B | 6.40B | 7.25B |
| Total current liabilities | 224.00M | 273.00M | 306.00M | 365.20M | 543.00M | 626.00M |
| Short-term debt | 92.00M | 104.00M | 103.00M | 120.05M | 162.00M | 221.00M |
| Long-term debt | 1.16B | 1.30B | 1.26B | 1.65B | 2.14B | 2.77B |
| Total liabilities | 1,544,000,000.00 | 1,740,000,000.00 | 1,750,000,000.00 | 2,195,432,000.00 | 3,082,000,000.00 | 3,847,000,000.00 |
| Total equity | 2.66B | 2.60B | 2.94B | 3.18B | 3.31B | 3.40B |
| Retained earnings | 1.49B | 1.27B | 1.37B | 1.45B | 1.37B | 1.42B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 52.38M | 85.39M | 92.20M | 240.53M | 771.38M | 276.79M | 265.08M | 283.79M |
| Depreciation & amortization | 30.42M | 32.09M | 34.17M | 57.64M | 62.88M | 90.94M | 93.44M | 72.42M |
| Free cash flow | -17.07M | 50.99M | 17.37M | 866.00K | 490.10M | -55.33M | -75.59M | 167.39M |
| Dividends paid | -764.78M | -65.17M | -120.12M | -100.21M | -740.92M | -150.36M | -200.55M | -267.94M |
| Stock buybacks / issuance | -- | -- | -- | 0 | 0 | -28.13M | -10.72M | -9.61M |
| Ending cash balance | 131.12M | 147.15M | 286.18M | 474.54M | 535.17M | 696.84M | 1.02B | 1.48B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 62.00M | 19.00M | 100.00M | 102.79M | -18.00M | 59.00M |
| Depreciation & amortization | 19.00M | 17.00M | 19.00M | 17.42M | 26.00M | 31.00M |
| Free cash flow | 49.00M | -6.00M | 71.00M | 53.39M | -144.00M | -233.00M |
| Dividends paid | 0 | -253.00M | -8.00M | -6.94M | 0 | -201.00M |
| Stock buybacks / issuance | -10.00M | 143.00M | -143.00M | 394.00K | 0 | 255.00M |
| Ending cash balance | 987.00M | 915.00M | 1.15B | 1.48B | 1.77B | 1.70B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 53.21 | -2.10 | 60.01 | 65.04 | 18.43 | -16.84 | 42.52 | 4.15 |
| ROA %i | 21.81 | -0.90 | 25.41 | 28.40 | 7.98 | -5.99 | 14.36 | 1.38 |
| ROIC %i | 26.88 | -0.78 | 31.77 | 38.95 | 11.81 | -8.01 | 22.49 | 2.76 |
| 5-year avg ROE %i | 17.57 | 7.73 | 18.45 | 40.92 | 38.92 | 24.91 | 33.83 | 22.66 |
| EBIT margin %i | 135.26 | 4.52 | 135.81 | 190.99 | 75.82 | -19.29 | 23.82 | 28.27 |
| FCF / sales %i | -- | 13.65 | 4.50 | 1.61 | 87.31 | -- | -- | 19.20 |
| Current ratioi | 3.64 | 3.14 | 4.04 | 1.30 | 5.50 | 3.05 | 6.91 | 4.94 |
| Quick ratioi | 1.90 | 1.92 | 3.98 | 1.23 | 5.15 | 2.96 | 6.83 | 4.85 |
| Debt / assetsi | 40.30 | 41.65 | 37.74 | 30.81 | 31.83 | 38.74 | 30.38 | 33.07 |
| LT debt / equityi | 86.78 | 93.33 | 82.14 | 66.16 | 71.57 | 117.75 | 74.11 | 104.45 |
| Interest coveragei | 16.21 | 0.75 | 21.51 | 17.94 | 9.15 | -2.55 | 2.09 | 3.52 |
| Revenue CAGR (3Y) %i | 3.76 | 4.82 | 1.86 | 10.25 | 15.40 | 21.42 | 15.49 | 14.96 |
| Net income CAGR (3Y) %i | 81.19 | -- | 28.93 | 28.91 | -- | -- | -13.71 | -40.38 |
| FCF CAGR (3Y) %i | -- | -- | -51.67 | -- | 112.62 | -- | -- | -30.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 46.14 | 39.40 | 35.75 | 4.15 | 5.17 | 8.09 |
| ROA %i | 14.58 | 11.85 | 10.81 | 1.38 | 1.51 | 2.06 |
| ROIC %i | 23.49 | 19.44 | 17.74 | 2.76 | 2.55 | 2.46 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 26.30 | 11.75 | 10.83 | 28.27 | 26.00 | 27.95 |
| FCF / sales %i | -- | 2.25 | 18.72 | 19.20 | -- | -- |
| Current ratioi | 5.45 | 4.33 | 4.66 | 4.94 | 3.74 | 3.22 |
| Quick ratioi | 5.34 | 4.22 | 4.54 | 4.85 | 3.66 | 3.13 |
| Debt / assetsi | 29.95 | 32.63 | 29.33 | 33.07 | 38.48 | 43.51 |
| LT debt / equityi | 72.85 | 94.38 | 84.97 | 104.45 | 153.16 | 187.95 |
| Interest coveragei | 2.28 | 1.14 | 1.62 | 3.52 | 3.35 | 3.78 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- OPC Israel is the largest reported line at 53.56% of revenue, across 2 reported segments.
- CPV Group follows at 46.44%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
OPC Israel53.56%
CPV Group46.44%
Quote time 2026-10-08 05:55:23 · For reference only, not investment advice and not tailored to your situation.